MCH ADVISORY RESEARCHMain site ↗
Industrials

Research & Consulting Services

7 companies under coverage.

Coverage

Research & Consulting Services


Equity Research

FTI Consulting Inc (FCN)

HOLD. 12-month probability-weighted target $162 (+7% vs spot). Gross Margin explains 71% of Monte Carlo outcome variance.

FCNEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -7.3%
Equity Research

Verisk Analytics Inc (VRSK)

HOLD. 12-month probability-weighted target $180 (+3% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

VRSKEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.9%
Equity Research

UL Solutions Inc. (ULS)

HOLD. 12-month probability-weighted target $69 (-6% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

ULSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -13.8%
Equity Research

Exponent Inc (EXPO)

SELL. 12-month probability-weighted target $62 (-9% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

EXPOEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -14.5%
Equity Research

TransUnion (TRU)

HOLD. 12-month probability-weighted target $77 (-1% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

TRUEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -17.4%
Equity Research

Equifax Inc (EFX)

SELL. 12-month probability-weighted target $156 (-9% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

EFXEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -23.8%
Equity Research

Booz Allen Hamilton Holding (BAH)

HOLD. 12-month probability-weighted target $66 (-8% vs spot). Gross Margin explains 71% of Monte Carlo outcome variance.

BAHEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -27.1%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed